(From left to right): Distribution Operating Director of PT Darya-Varia Laboratoria Tbk, Jasbir Singh; President Director of PT Darya-Varia Laboratoria Tbk, Dr. Ian Kloer; President Director of PT Anugerah Pharmindo Lestari (APL), Christophe Piganiol; Management of PT Bersama Indonesia Gerakkan, Dhanie Hariadi; and Professional Healthcare Group Operating Director of PT Darya-Varia Laboratoria Tbk, Deddy Septiadi.
In Indonesia, the demand for advanced wound care solutions, particularly Negative Pressure Wound Therapy (NPWT), has increased over the years. NPWT is a modern non-invasive therapy that utilizes negative pressure to accelerate wound healing and has shown remarkable effectiveness in treating various types of wounds, including acute and chronic wounds.
However, despite the clear benefits of NPWT, healthcare providers in Indonesia face a significant challenge, limited availability of NPWT machines, hindering timely and effective treatment for patients in need.
Recognizing the importance of ensuring access to cutting-edge medical technology for the entire Indonesian population, especially for wound care, PT Darya-Varia Laboratoria Tbk is addressing the NPWT shortage and facilitating widespread innovative therapy starting in 2024. This mission is carried out in collaboration with PT Bersama Indonesia Gerakkan and PT Anugerah Pharmindo Lestari.
On February 2nd, 2024, PT Darya-Varia Laboratoria Tbk formalized its strategic partnership with PT Bersama Indonesia Gerakkan and PT Anugerah Pharmindo Lestari in regards to expanding market for innovative healthcare products. This collaboration was inaugurated through a memorandum of understanding signing event represented by President Director of PT Darya-Varia Laboratoria Tbk, Dr. Ian Kloer; President Director of PT Anugerah Pharmindo Lestari, Christophe Piganiol; and Management of PT Bersama Indonesia Gerakkan, Dhanie Hariadi.
NPWT products under the brand WELSUC include machines and disposable medical supplies such as canisters for holding wound fluid and wound foam kits in three sizes: S, M, L. This product is designed to provide optimal care, reduce the risk of infection, and accelerate the healing process. Another advantage of this product is its user-friendly design. With a user-friendly design, WELSUC can be used practically by medical professionals and provides maximum comfort for patients.
The collaboration between PT Darya-Varia Laboratoria Tbk, PT Bersama Indonesia Gerakkan, and PT Anugerah Pharmindo Lestari committed an optimal marketing for this innovative product. With a wide distribution network and a strong reputation in the healthcare sector, this collaboration is expected to reach various regions in Indonesia.
"With this collaboration, we are committed to providing the best solutions in wound care through the innovative Welsuc Negative Pressure Wound Therapy product. We believe that through joint efforts with PT Bersama Indonesia Gerakkan and PT Anugerah Pharmindo Lestari, we can make a positive impact to the Indonesian community," said Dr. Ian Kloer, President Director of PT Darya-Varia Laboratoria Tbk.
This collaboration marks a positive step in bringing a higher quality future to healthcare services in Indonesia. With a focus on innovation, efficiency, and product quality, PT Darya-Varia Laboratoria Tbk, PT Bersama Indonesia Gerakkan, and PT Anugerah Pharmindo Lestari are together taking concrete steps to contribute to health quality improvement through superior products.